Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
McKesson
Mallinckrodt
Boehringer Ingelheim

Last Updated: November 27, 2022

Safinamide mesylate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for safinamide mesylate and what is the scope of patent protection?

Safinamide mesylate is the generic ingredient in one branded drug marketed by Mdd Us and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Safinamide mesylate has ninety-seven patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for safinamide mesylate

US Patents and Regulatory Information for safinamide mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mdd Us XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Mdd Us XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Mdd Us XADAGO safinamide mesylate TABLET;ORAL 207145-001 Mar 21, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mdd Us XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mdd Us XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for safinamide mesylate

Country Patent Number Title Estimated Expiration
Taiwan I393700 See Plans and Pricing
Hungary S1500043 See Plans and Pricing
Spain 2527437 See Plans and Pricing
Portugal 2070526 See Plans and Pricing
Russian Federation 2342929 СПОСОБЫ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА (METHODS OF PARKINSON'S DISEASE TREATMENT) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for safinamide mesylate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1613296 15C0054 France See Plans and Pricing PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
1613296 C20150033 00258 Estonia See Plans and Pricing PRODUCT NAME: SAFINAMIID;REG NO/DATE: EU/1/14/984 26.02.2015
1613296 46/2015 Austria See Plans and Pricing PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
1613296 241 50017-2015 Slovakia See Plans and Pricing PRODUCT NAME: SAFINAMID; REGISTRATION NO/DATE: EU/1/14/984/001 - EU/1/14/984/010 20150226
1613296 122015000058 Germany See Plans and Pricing PRODUCT NAME: XADAGO; REGISTRATION NO/DATE: EU/1/14/984 20150224
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Boehringer Ingelheim
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.